+
in $
+103.77%
MSP Recovery, Inc.
in NT$
-0.79%
Makalot Industrial Co., Ltd.
1477.TW LIFW
Price 312.00 3.24
Movement -NT$ 2.50 +$ 1.65
Market Cap. 77.0 B 22.4 M
Volume 1.6 M 29.1 M
Volume μ 1.7 M 1.3 M
EPS TTM 16.39 -141.50
P/E TTM 19.04 -0.02
Dividend Yield TTM 7% -%
Shares Outstanding 246 M 6 M
Earnings Call March 11, 2025 Nov. 14, 2024

Financial Comparison

Financial Statements
Click to show
LIFW
1477.TW
    • 2023
    • 2022
    • 2021
    • 2020
Profitability
Industry Average
Profit Margin
+95.67% YoY
-0.42
-0.32
-7.31
Gross Margin
+101.49% YoY
-2.88
0.91
-61.15
Operating Margin
+80.52% YoY
-4.03
-14.15
-72.66
EBT Margin
+84.17% YoY
-6.02
-17.16
-108.39
ETR
-% YoY
-
-
EPS
+52.53% YoY
0.30
-3.00
-6.32
EPS Dil.
+52.53% YoY
0.28
-3.00
-6.32
ROA
+87.64% YoY
0.00
0.00
-0.02
ROE
+67.33% YoY
0.00
-0.07
-0.21
ROIC
-816.88% YoY
0.01
-0.36
-0.04
Takeaways
  • Negative 5Y revenue growth of --92.68% and +69.35% for the past 10 Years
  • The profit margin of -7.31 implies a negative sign compared to the industry avg. of -0.42
Market Prospects
P/E
-3,614.01% YoY
-5.01
-13.34
-0.36
P/B
-1,113.73% YoY
3.62
0.90
0.07
P/TB
-1,113.73% YoY
3.62
0.90
0.07
Earnings Yield
+97.31% YoY
-0.16
-0.07
-2.78
Other Metrics
EBITDA[in mil.]
+98.73% YoY
-
-1
-83
EBITDA Margin
+99.58% YoY
-0.53
-0.05
-10.79
WA[in mil.]
+72.26% YoY
-
2
8
WA Dil.[in mil.]
+72.26% YoY
-
2
8
Earnings & Forecasts
  • Hide e
    Reported
    Avg. Estimate
    Beat
    Miss
Next Earnings LIFW 1477.TW
Earnings Call Nov. 14, 2024 Aug. 2, 2024
Avg. EPS Forecast - 3.75
Potential Delta 2 % %
Avg. Revenue Forecast - Mil. 7,851 Mil.
Potential Delta - % - %
Dividends
Company Average
Makalot Industrial Co., Ltd.
NT$11.63
Industry Average
Apparel - Manufacturers
NT$2.17

Investor Relations

Index
LIFW
Annual Statement n/a
Quarterly Statement n/a
Earnings Call n/a
Next Earnings Call tba
Shareholder Meeting n/a
Dividend n/a
FDA Filing n/a
Lobby Disclosure n/a
1477.TW
Annual Statement n/a
Quarterly Statement n/a
Earnings Call n/a
Next Earnings Call March 11, 2025
Shareholder Meeting n/a
FDA Filing n/a
Lobby Disclosure n/a

Strategic Comparison

Risks & Opportunities

Yet not available for any. Try a different selection.